|
Immunotherapy
Citations 221-230 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Immunogenicity of Bcl-2 in patients with cancer
- Mads Hald Andersen, Inge Marie Svane, Pia Kvistborg, Ove Juul Nielsen, Eva Balslev, Sine Reker, Jürgen C. Becker, and Per thor Straten
Blood 2005; 105: 728-734.
[Abstract]
[Full text]
[PDF]
Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy
- Daniel J. Powell, Jr, Mark E. Dudley, Paul F. Robbins, and Steven A. Rosenberg
Blood 2005; 105: 241-250.
[Abstract]
[Full text]
[PDF]
Modulation of cord blood CD8+ T-cell effector differentiation by TGF- 1 and 4-1BB costimulation
- Young-June Kim, Teresa M. Stringfield, Yan Chen, and Hal E. Broxmeyer
Blood 2005; 105: 274-281.
[Abstract]
[Full text]
[PDF]
Alpha phenyl-tert-butyl nitrone (PBN) protects syngeneic marrow transplant recipients from the lethal cytokine syndrome occurring after agonistic CD40 antibody administration
- Maria Gendelman, Nadine Halligan, Richard Komorowski, Brent Logan, William J. Murphy, Bruce R. Blazar, Kirkwood A. Pritchard, Jr, and William R. Drobyski
Blood 2005; 105: 428-431.
[Abstract]
[Full text]
[PDF]
FTY720 suppresses humoral immunity by inhibiting germinal center reaction
- Shuhua Han, Xuejun Zhang, Gangdou Wang, Hui Guan, Gabriela Garcia, Ping Li, Lili Feng, and Biao Zheng
Blood 2004; 104: 4129-4133.
[Abstract]
[Full text]
[PDF]
Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15
- Maria Wysocka, Bernice M. Benoit, Sarah Newton, Livio Azzoni, Luis J. Montaner, and Alain H. Rook
Blood 2004; 104: 4142-4149.
[Abstract]
[Full text]
[PDF]
Distinct homeostatic requirements of CD4+ and CD4- subsets of V 24-invariant natural killer T cells in humans
- Denis V. Baev, Xiao-hui Peng, Liping Song, Jerry R. Barnhart, Gay M. Crooks, Kenneth I. Weinberg, and Leonid S. Metelitsa
Blood 2004; 104: 4150-4156.
[Abstract]
[Full text]
[PDF]
Adoptive immunotherapy of BCR-ABL–induced chronic myeloid leukemia–like myeloproliferative disease in a murine model
- Daniela S. Krause and Richard A. Van Etten
Blood 2004; 104: 4236-4244.
[Abstract]
[Full text]
[PDF]
Cytotoxic activity of the maytansinoid immunoconjugate B-B4–DM1 against CD138+ multiple myeloma cells
- Pierfrancesco Tassone, Victor S. Goldmacher, Paola Neri, Antonella Gozzini, Masood A. Shammas, Kathleen R. Whiteman, Linda L. Hylander-Gans, Daniel R. Carrasco, Teru Hideshima, Reshma Shringarpure, Jialan Shi, Charles K. Allam, John Wijdenes, Salvatore Venuta, Nikhil C. Munshi, and Kenneth C. Anderson
Blood 2004; 104: 3688-3696.
[Abstract]
[Full text]
[PDF]
Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies
- Rhona Stein, Zhengxing Qu, Thomas M. Cardillo, Susan Chen, Adriane Rosario, Ivan D. Horak, Hans J. Hansen, and David M. Goldenberg
Blood 2004; 104: 3705-3711.
[Abstract]
[Full text]
[PDF]
|
|
